This information was published on 2024-12-26T04:24:43 for IP Right Filed Published.
| Field | Value |
| (210) | 2509904 (IR 1830313) |
| (220) |
13 Nov 2024
|
| (300) |
CH, 31 May 2024, 817324
|
| (511) (510) |
Class 5
Pharmaceutical products; biotechnological products for medical purposes; therapeutic drugs and active ingredients; pharmaceutical preparations for the treatment and/or prevention of cancer; biopharmaceuticals for the treatment and/or prevention of cancer; pharmaceutical preparations for the treatment and/or prevention of autoimmune and inflammatory diseases; pharmaceutical preparations for the treatment and/or prevention of skin diseases (dermatology), neurodegenerative and metabolic diseases. Class 42 Research and development services in the field of biotechnology; research for medical purposes in the field of cancer, autoimmune and inflammatory diseases, skin diseases (dermatology), neurodegenerative and metabolic diseases. |
| (540) | MONTE ROSA THERAPEUTICS |
| (550) | Word |
| (730) |
Monte Rosa Therapeutics AG
|
Find out more about publications on the About page.